NO20034022L - En kombinasjon omfattende combretastatin og anticancermidler - Google Patents

En kombinasjon omfattende combretastatin og anticancermidler

Info

Publication number: NO20034022L
Authority: NO; Norway
Prior art keywords: combretastatin; combination; anticancer agents; anticancer; agents
Prior art date: 2001-03-15

Application number

NO20034022A

Other languages

English (en)

Other versions

NO332661B1 (no

NO20034022D0 (no

Inventor

Marie-Christine Bissery

Original Assignee

Aventis Pharma Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-03-15

Filing date

2002-03-15

Publication date

2003-09-11

2002-03-15 Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa

2003-09-11 Publication of NO20034022D0 publication Critical patent/NO20034022D0/no

2003-09-11 Publication of NO20034022L publication Critical patent/NO20034022L/no

2012-11-26 Publication of NO332661B1 publication Critical patent/NO332661B1/no

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/075—Ethers or acetals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/075—Ethers or acetals
- A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
- A61K31/09—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon having two or more such linkages
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/136—Amines having aromatic rings, e.g. ketamine, nortriptyline having the amino group directly attached to the aromatic ring, e.g. benzeneamine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/243—Platinum; Compounds thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Molecular Biology (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Inorganic Chemistry (AREA)
Engineering & Computer Science (AREA)
Oncology (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines Containing Plant Substances (AREA)

NO20034022A 2001-03-15 2002-03-15 Farmasoytisk kombinasjon omfattende combretastatin og anticancerforbindelser NO332661B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US27562701P	2001-03-15	2001-03-15
PCT/EP2002/006758 WO2004037258A1 (en)	2001-03-15	2002-03-15	A combination comprising combretastatin and anticancer agents

Publications (3)

Publication Number	Publication Date
NO20034022D0 NO20034022D0 (no)	2003-09-11
NO20034022L true NO20034022L (no)	2003-09-11
NO332661B1 NO332661B1 (no)	2012-11-26

Family

ID=23053164

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20034022A NO332661B1 (no)	2001-03-15	2002-03-15	Farmasoytisk kombinasjon omfattende combretastatin og anticancerforbindelser

Country Status (37)

Country	Link
US (4)	US20020183266A1 (no)
EP (1)	EP1439839B8 (no)
JP (1)	JP4991107B2 (no)
KR (1)	KR100849610B1 (no)
CN (2)	CN1290504C (no)
AR (1)	AR032989A1 (no)
AT (1)	ATE433750T1 (no)
AU (1)	AU2002304574B2 (no)
BR (1)	BR0208017A (no)
CA (2)	CA2673449C (no)
CY (1)	CY1109364T1 (no)
CZ (1)	CZ302451B6 (no)
DE (1)	DE60232673D1 (no)
DK (1)	DK1439839T3 (no)
EA (1)	EA006316B1 (no)
EC (1)	ECSP034766A (no)
ES (1)	ES2327617T3 (no)
HR (1)	HRPK20030734B3 (no)
HU (1)	HU228510B1 (no)
IL (2)	IL157891A0 (no)
MA (1)	MA27000A1 (no)
ME (2)	MEP16208A (no)
MX (1)	MXPA03007552A (no)
NO (1)	NO332661B1 (no)
NZ (1)	NZ527526A (no)
PE (1)	PE20020909A1 (no)
PL (1)	PL205728B1 (no)
PT (1)	PT1439839E (no)
RS (1)	RS50682B (no)
SI (1)	SI1439839T1 (no)
SK (1)	SK287908B6 (no)
TN (1)	TNSN03060A1 (no)
TW (1)	TWI306028B (no)
UA (1)	UA75127C2 (no)
UY (1)	UY27208A1 (no)
WO (2)	WO2002074229A2 (no)
ZA (1)	ZA200306789B (no)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE69931766T2 (de) *	1998-04-03	2007-05-31	Ajinomoto Co., Inc.	Antitumorale mittel
US20050209310A1 (en) *	2000-12-22	2005-09-22	Chaplin David J	Methods for modulating tumor growth and metastasis
GB0410817D0 (en) *	2004-05-14	2004-06-16	Angiogene Pharm Ltd	Vascular damaging therapy
CN100431606C (zh) *	2004-11-22	2008-11-12	山东蓝金生物工程有限公司	一种抗癌药物组合物
CN1319978C (zh) *	2005-04-06	2007-06-06	西南合成制药股份有限公司	康布瑞汀化合物的制备方法
FR2895258B1 (fr) *	2005-12-22	2008-03-21	Aventis Pharma Sa	Combinaison comprenant de la combretastatine et des agents anticancereux
US20080104512A1 (en) *	2006-10-31	2008-05-01	Motorola, Inc.	Method and apparatus for providing realtime feedback in a voice dialog system
WO2009067706A1 (en) *	2007-11-21	2009-05-28	Oxigene, Inc.	Method for treating hematopoietic neoplasms
US20090209496A1 (en) *	2008-02-15	2009-08-20	David Chaplin	Methods and compositions for enhancing the efficacy of rtk inhibitors
FR2939665B1 (fr) *	2008-12-12	2011-10-07	Sanofi Aventis	Combinaison antitumorale associant l'ave8062a et le docetaxel
FR2945210B1 (fr) *	2009-05-07	2011-07-01	Sanofi Aventis	Combinaison antitumorale comprenant l'ave8062 et le sorafenib
EP2397135A1 (en)	2010-06-18	2011-12-21	Sanofi	An antitumoral combination comprising ombrabulin, a taxane derivative and a platinum derivative
MX2012014732A (es)	2010-06-18	2013-01-22	Sanofi Sa	Una combinacion antitumoral que comprende ombrabulina un derivado de taxano y un derivado de platino.
EP2481404A1 (en)	2010-11-15	2012-08-01	Sanofi	An antitumoral combination comprising ombrabulin, a taxane derivative and a platinum derivative
EP2407161A1 (en)	2010-07-13	2012-01-18	Sanofi	An antitumoral combination comprising ombrabulin and bevacizumab
FR2968557A1 (fr)	2010-12-09	2012-06-15	Sanofi Aventis	Combinaison antitumorale comprenant un derive de la famille des combretastatines et le cetuximab
FR2978663A1 (fr)	2011-08-01	2013-02-08	Sanofi Sa	Combinaison antitumorale comprenant l'ombrabuline et le cetuximab, associee a la radiotherapie
FR2978662A1 (fr)	2011-08-01	2013-02-08	Sanofi Sa	Combinaison antitumorale comprenant l'ombrabuline et le cisplatine, associee a la radiotherapie
JP2018523712A (ja)	2015-08-18	2018-08-23	マテオンセラピューティクス, インク.Mateon Therapeutics, Inc.	腫瘍に対する免疫調節療法を向上させる為のｖｄａｓの使用
US9980953B2 (en) *	2016-09-26	2018-05-29	Chong Kun Dang Pharmaceutical Corp.	Combined composition for preventing or treating cancer comprising a benzophenone thiazole derivatives as a VDA and topoisomerase inhibitor

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2601675B1 (fr)	1986-07-17	1988-09-23	Rhone Poulenc Sante	Derives du taxol, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2601676B1 (fr) *	1986-07-17	1988-09-23	Rhone Poulenc Sante	Procede de preparation du taxol et du desacetyl-10 taxol
US4996237A (en) *	1987-01-06	1991-02-26	Arizona Board Of Regents	Combretastatin A-4
MX9102128A (es)	1990-11-23	1992-07-08	Rhone Poulenc Rorer Sa	Derivados de taxano,procedimiento para su preparacion y composicion farmaceutica que los contiene
US5430062A (en) *	1992-05-21	1995-07-04	Research Corporation Technologies, Inc.	Stilbene derivatives as anticancer agents
US5731353A (en) *	1993-09-08	1998-03-24	Ajinomoto Co., Inc.	Stilbene derivatives and pharmaceutical compositions containing them
TW325458B (en) *	1993-09-08	1998-01-21	Ajinomoto Kk	Stilbene derivatives and pharmaceutical compositions comprising the same for anti-cancer
US5561122A (en) *	1994-12-22	1996-10-01	Arizona Board Of Regents Acting On Behalf Of Arizona State University	Combretastatin A-4 prodrug
TW334418B (en) *	1995-03-07	1998-06-21	Ajinomoto Kk	Stilbene derivatives and pharmaceutical compositions
DE69931766T2 (de) *	1998-04-03	2007-05-31	Ajinomoto Co., Inc.	Antitumorale mittel
US6242770B1 (en) *	1998-08-31	2001-06-05	Gary Bela Bronner	Diode connected to a magnetic tunnel junction and self aligned with a metallic conductor and method for forming the same
GB9903404D0 (en) *	1999-02-16	1999-04-07	Angiogene Pharm Ltd	Methods of treatment and compositions useful for the treatment of diseases involving angiogenesis
US6664288B1 (en) *	1999-04-14	2003-12-16	Dana Farber Cancer Institute, Inc.	Method and composition for the treatment of cancer
US6465448B1 (en) *	1999-08-13	2002-10-15	Case Western Reserve University	Methoxyamine potentiation of temozolomide anti-cancer activity
US6448030B1 (en) *	2000-02-18	2002-09-10	University Of Nevada-Las Vegas	Method for predicting the efficacy of anti-cancer drugs
SK5122003A3 (en) *	2000-10-27	2003-12-02	Aventis Pharma Sa	A combination comprising camptothecin and a stilbene derivative for the treatment of cancer
CA2432792C (en) *	2000-12-22	2012-04-03	Bristol-Myers Squibb Company	Methods for modulating tumor growth and metastasis
US6466448B1 (en) *	2001-06-11	2002-10-15	Network Appliance, Inc.	Riser board retaining and air ducting structure for printed circuit boards

2002
- 2002-03-08 US US10/092,508 patent/US20020183266A1/en not_active Abandoned
- 2002-03-14 AR ARP020100914A patent/AR032989A1/es unknown
- 2002-03-14 UY UY27208A patent/UY27208A1/es not_active Application Discontinuation
- 2002-03-15 TW TW091104922A patent/TWI306028B/zh not_active IP Right Cessation
- 2002-03-15 BR BR0208017-6A patent/BR0208017A/pt not_active IP Right Cessation
- 2002-03-15 AU AU2002304574A patent/AU2002304574B2/en not_active Ceased
- 2002-03-15 NO NO20034022A patent/NO332661B1/no not_active IP Right Cessation
- 2002-03-15 WO PCT/EP2002/003322 patent/WO2002074229A2/en not_active Ceased
- 2002-03-15 SI SI200230915T patent/SI1439839T1/sl unknown
- 2002-03-15 ME MEP-162/08A patent/MEP16208A/xx unknown
- 2002-03-15 CN CNB028065832A patent/CN1290504C/zh not_active Expired - Fee Related
- 2002-03-15 HU HU0600233A patent/HU228510B1/hu not_active IP Right Cessation
- 2002-03-15 SK SK1155-2003A patent/SK287908B6/sk not_active IP Right Cessation
- 2002-03-15 IL IL15789102A patent/IL157891A0/xx unknown
- 2002-03-15 CA CA2673449A patent/CA2673449C/en not_active Expired - Fee Related
- 2002-03-15 PL PL374406A patent/PL205728B1/pl not_active IP Right Cessation
- 2002-03-15 HR HR20030734A patent/HRPK20030734B3/xx not_active IP Right Cessation
- 2002-03-15 DK DK02732758T patent/DK1439839T3/da active
- 2002-03-15 CA CA002470484A patent/CA2470484C/en not_active Expired - Fee Related
- 2002-03-15 UA UA2003109292A patent/UA75127C2/uk unknown
- 2002-03-15 AT AT02732758T patent/ATE433750T1/de active
- 2002-03-15 ES ES02732758T patent/ES2327617T3/es not_active Expired - Lifetime
- 2002-03-15 JP JP2004545736A patent/JP4991107B2/ja not_active Expired - Fee Related
- 2002-03-15 PE PE2002000204A patent/PE20020909A1/es not_active Application Discontinuation
- 2002-03-15 NZ NZ527526A patent/NZ527526A/en not_active IP Right Cessation
- 2002-03-15 KR KR1020037012033A patent/KR100849610B1/ko not_active Expired - Fee Related
- 2002-03-15 CN CN2006101388753A patent/CN1935134B/zh not_active Expired - Fee Related
- 2002-03-15 EP EP02732758A patent/EP1439839B8/en not_active Expired - Lifetime
- 2002-03-15 WO PCT/EP2002/006758 patent/WO2004037258A1/en not_active Ceased
- 2002-03-15 ME MEP-2008-162A patent/ME00056B/me unknown
- 2002-03-15 US US10/097,926 patent/US6933320B2/en not_active Expired - Fee Related
- 2002-03-15 MX MXPA03007552A patent/MXPA03007552A/es active IP Right Grant
- 2002-03-15 RS YUP-713/03A patent/RS50682B/sr unknown
- 2002-03-15 PT PT02732758T patent/PT1439839E/pt unknown
- 2002-03-15 DE DE60232673T patent/DE60232673D1/de not_active Expired - Lifetime
- 2002-03-15 CZ CZ20032476A patent/CZ302451B6/cs not_active IP Right Cessation
- 2002-03-15 EA EA200301015A patent/EA006316B1/ru not_active IP Right Cessation
2003
- 2003-07-08 TN TNPCT/EP2002/003322A patent/TNSN03060A1/en unknown
- 2003-08-29 ZA ZA2003/06789A patent/ZA200306789B/en unknown
- 2003-09-09 MA MA27301A patent/MA27000A1/fr unknown
- 2003-09-11 IL IL157891A patent/IL157891A/en not_active IP Right Cessation
- 2003-09-12 EC EC2003004766A patent/ECSP034766A/es unknown
2004
- 2004-11-23 US US10/995,998 patent/US20050075295A1/en not_active Abandoned
2007
- 2007-02-21 US US11/677,178 patent/US20070149476A1/en not_active Abandoned
2009
- 2009-09-16 CY CY20091100954T patent/CY1109364T1/el unknown

Also Published As

Publication number	Publication date
IL157891A0 (en)	2004-03-28
CN1547471A (zh)	2004-11-17
EA200301015A1 (ru)	2004-08-26
CZ302451B6 (cs)	2011-05-25
CZ20032476A3 (en)	2004-07-14
ME00056B (me)	2010-06-10
CA2673449C (en)	2011-10-18
MXPA03007552A (es)	2004-10-15
EA006316B1 (ru)	2005-10-27
NO332661B1 (no)	2012-11-26
AR032989A1 (es)	2003-12-03
CN1290504C (zh)	2006-12-20
CA2470484A1 (en)	2004-05-06
MEP16208A (en)	2010-06-10
CA2470484C (en)	2009-10-13
HRPK20030734B3 (en)	2006-11-30
ES2327617T3 (es)	2009-11-02
US20030060429A1 (en)	2003-03-27
UA75127C2 (en)	2006-03-15
JP2005522527A (ja)	2005-07-28
US20020183266A1 (en)	2002-12-05
HU228510B1 (en)	2013-03-28
NZ527526A (en)	2006-11-30
HRP20030734A2 (en)	2005-06-30
AU2002304574A1 (en)	2004-05-13
KR100849610B1 (ko)	2008-07-31
AU2002304574B2 (en)	2005-09-15
TNSN03060A1 (en)	2005-12-23
SK11552003A3 (sk)	2004-03-02
YU71303A (sh)	2006-08-17
DK1439839T3 (da)	2009-10-05
CN1935134A (zh)	2007-03-28
WO2002074229A2 (en)	2002-09-26
DE60232673D1 (de)	2009-07-30
US20070149476A1 (en)	2007-06-28
SK287908B6 (sk)	2012-03-02
US20050075295A1 (en)	2005-04-07
PL205728B1 (pl)	2010-05-31
RS50682B (sr)	2010-06-30
EP1439839B1 (en)	2009-06-17
HUP0600233A2 (en)	2008-06-30
EP1439839A1 (en)	2004-07-28
EP1439839B8 (en)	2010-09-01
HK1067039A1 (en)	2005-04-01
PE20020909A1 (es)	2002-12-09
CN1935134B (zh)	2010-12-15
IL157891A (en)	2010-06-16
ECSP034766A (es)	2003-10-28
CA2673449A1 (en)	2004-05-06
ATE433750T1 (de)	2009-07-15
WO2004037258A1 (en)	2004-05-06
SI1439839T1 (sl)	2011-09-30
ZA200306789B (en)	2005-02-23
PL374406A1 (en)	2005-10-17
TWI306028B (en)	2009-02-11
MA27000A1 (fr)	2004-12-20
BR0208017A (pt)	2004-12-07
PT1439839E (pt)	2009-09-03
NO20034022D0 (no)	2003-09-11
CY1109364T1 (el)	2014-07-02
HUP0600233A3 (en)	2010-03-29
KR20040067866A (ko)	2004-07-30
JP4991107B2 (ja)	2012-08-01
US6933320B2 (en)	2005-08-23
UY27208A1 (es)	2002-08-30

Publication	Publication Date	Title
NO20034022D0 (no)	2003-09-11	En kombinasjon omfattende combretastatin og anticancermidler
DE60139354D1 (de)	2009-09-03	Thrombopoietin-Mimetika
IS7291A (is)	2004-06-01	Merkt kirni
NO20024874D0 (no)	2002-10-09	Benzoamidpiperidin-holdige forbindelser og beslektede forbindelser
DK1416797T3 (da)	2010-09-20	Artropodicide anthranilamider
DE60214961D1 (de)	2006-11-09	Anzeigegerät
DE60209567D1 (de)	2006-04-27	Schraubverschluss
NO20034159L (no)	2003-09-18	Östrogen-gestagen-kombinasjonspreparat og anvendelse derav
NO20032821D0 (no)	2003-06-19	Sea-trosy og beslektede fremgangsmåter
NO20034785L (no)	2003-12-23	Farmas degree ytiske kombinasjoner basert på pyridoindolonderivater og anticancer-midler
DE60205008D1 (de)	2005-08-18	Kettelverfahren und -vorrichtung
DE60215736D1 (de)	2006-12-14	Eine Gehäuseanordnung
DE60219418T8 (de)	2008-04-30	Silanylphenole und -naphthole
AU2002302465A1 (en)	2002-10-03	A combination comprising combretastatin and anticancer agents
DE50115276D1 (de)	2010-02-04	Elektrodynamischer biegemomententreiber
ITMI20011210A0 (it)	2001-06-08	Corticosteroidi-21-glicolati e 21-acilglicolati
SE0103104D0 (sv)	2001-09-18	A composition and use thereof
DOP2001000232A (es)	2002-09-30	Combinación terapeutica
NO20015559D0 (no)	2001-11-14	Kreklinggel±
SE0103814D0 (sv)	2001-11-16	Räddningsanordning
SE0101165D0 (sv)	2001-03-30	Räddningsanordning
FIU20010131U0 (fi)	2001-03-23	Pelastuslaitteisto
FI20012505A0 (fi)	2001-12-19	Pelastuslaite
ITRM20010077V0 (it)	2001-04-10	Linea alcione
UA5022S (uk)	2001-07-16	Емблема

Legal Events

Date	Code	Title	Description
2014-11-03	MM1K	Lapsed by not paying the annual fees